Logotype for Gossamer Bio Inc

Gossamer Bio (GOSS) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Gossamer Bio Inc

Proxy Filing summary

2 Dec, 2025

Executive summary

  • Annual meeting scheduled for June 25, 2025, to be held virtually, with registration required by June 24, 2025.

  • Four key proposals: election of three Class I directors, ratification of Ernst & Young LLP as auditor, advisory vote on executive compensation, and approval of amended 2019 Incentive Award Plan.

  • Board recommends voting in favor of all proposals.

Voting matters and shareholder proposals

  • Election of three Class I directors for three-year terms expiring in 2028.

  • Ratification of Ernst & Young LLP as independent auditor for 2025.

  • Advisory vote on executive compensation (say-on-pay).

  • Approval of amendment and restatement of the 2019 Incentive Award Plan, including an increase of 11,350,000 shares and extension of the plan term to 2035.

  • Shareholder proposals for the 2026 meeting must be received by December 30, 2025.

Board of directors and corporate governance

  • Board consists of seven members, with a majority deemed independent under Nasdaq rules.

  • Board leadership includes a combined Chairman/CEO and a lead independent director.

  • Three standing committees: audit, compensation, and nominating/corporate governance, all with independent members.

  • Annual review of board composition and director qualifications, with a focus on diversity and relevant expertise.

  • Non-employee director compensation program updated in February 2025 to increase committee retainers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more